Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2015 2
2016 1
2017 3
2018 2
2019 1
2020 4
2021 3
2022 7
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Mini Percutaneous Nephrolithotomy Is a Noninferior Modality to Standard Percutaneous Nephrolithotomy for the Management of 20-40mm Renal Calculi: A Multicenter Randomized Controlled Trial.
Zeng G, Cai C, Duan X, Xu X, Mao H, Li X, Nie Y, Xie J, Li J, Lu J, Zou X, Mo J, Li C, Li J, Wang W, Yu Y, Fei X, Gu X, Chen J, Kong X, Pang J, Zhu W, Zhao Z, Wu W, Sun H, Liu Y, la Rosette J. Zeng G, et al. Eur Urol. 2021 Jan;79(1):114-121. doi: 10.1016/j.eururo.2020.09.026. Epub 2020 Sep 29. Eur Urol. 2021. PMID: 32994063 Clinical Trial.
Sintilimab combined with apatinib plus capecitabine in the treatment of unresectable hepatocellular carcinoma: A prospective, open-label, single-arm, phase II clinical study.
Li D, Xu L, Ji J, Bao D, Hu J, Qian Y, Zhou Y, Chen Z, Li D, Li X, Zhang X, Wang H, Yi C, Shi M, Pang Y, Liu S, Xu X. Li D, et al. Front Immunol. 2022 Aug 26;13:944062. doi: 10.3389/fimmu.2022.944062. eCollection 2022. Front Immunol. 2022. PMID: 36091003 Free PMC article. Clinical Trial.
Comparison of short interval and low dose (SILD) with high dose of cyclophosphamide in the susceptibility to infection in SLE: a multicentrereal-world study.
Shao M, Miao M, Zhang X, Zhang X, An Y, Guo H, Lei L, Zhao Q, Ding Y, Lin J, Wu R, Yu F, Li Y, Miao H, Zhang L, Du Y, Jiao R, Pang L, Long L, Yao X, Shi X, Wang F, Cui L, Zhang L, Liu S, Lu F, Luo K, Zhao S, Wang Y, Wu X, Wang Q, Liu H, Song S, Zhou X, Zhang X, Shi S, Zhu H, Chen Y, Yu H, Wu J, Yu R, Fan W, Liu S, Xu J, Chen Z, Shi L, He J, Zhang X, Li Z, Li R. Shao M, et al. Lupus Sci Med. 2022 Nov;9(1):e000779. doi: 10.1136/lupus-2022-000779. Lupus Sci Med. 2022. PMID: 36351697 Free PMC article.
Coronavirus disease 2019 in pregnant women: a report based on 116 cases.
Yan J, Guo J, Fan C, Juan J, Yu X, Li J, Feng L, Li C, Chen H, Qiao Y, Lei D, Wang C, Xiong G, Xiao F, He W, Pang Q, Hu X, Wang S, Chen D, Zhang Y, Poon LC, Yang H. Yan J, et al. Am J Obstet Gynecol. 2020 Jul;223(1):111.e1-111.e14. doi: 10.1016/j.ajog.2020.04.014. Epub 2020 Apr 23. Am J Obstet Gynecol. 2020. PMID: 32335053 Free PMC article.
Recombinant human endostatin injection (Endostar) combined with PF chemotherapy and sequential intensity-modulated radiotherapy is tolerable and improves prognosis of locally advanced nasopharyngeal carcinoma: a randomized, open, multicenter phase II clinical study.
Xu L, Li D, Ji J, Chen Z, Tang X, Chen D, Li X, Bao D, Yan F, Pang Y, Liu S, Zhou Y, Xu X. Xu L, et al. Am J Cancer Res. 2022 Oct 15;12(10):4622-4636. eCollection 2022. Am J Cancer Res. 2022. PMID: 36381335 Free PMC article.
27 results